Oracle (ORCL)
(Delayed Data from NYSE)
$142.76 USD
+0.69 (0.49%)
Updated Jul 11, 2024 04:00 PM ET
Pre-Market: $142.88 +0.12 (0.08%) 9:16 AM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Brokerage Reports
Oracle Corporation [ORCL]
Reports for Purchase
Showing records 181 - 200 ( 912 total )
Company: Oracle Corporation
Industry: Computer - Software
Comprehensive Technical and Fundamental Analysis for ORCL.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Oracle Corporation
Industry: Computer - Software
Provider: Zacks Investment Research
Analyst: Research Department
Company: Oracle Corporation
Industry: Computer - Software
Company: Oracle Corporation
Industry: Computer - Software
Cerner Accretive but Non-Strategic, in Our View, Downgrading to Sector Weight
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Oracle Corporation
Industry: Computer - Software
Company: Oracle Corporation
Industry: Computer - Software
Company: Oracle Corporation
Industry: Computer - Software
Cerner Accretive but Non-Strategic, in Our View, Downgrading to Sector Weight
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Oracle Corporation
Industry: Computer - Software
Provider: Zacks Investment Research
Analyst: Research Department
Company: Oracle Corporation
Industry: Computer - Software
Company: Oracle Corporation
Industry: Computer - Software
Announces Anticipated Acquisition of Cerner for $28B in Equity
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Oracle Corporation
Industry: Computer - Software
Provider: Zacks Investment Research
Analyst: Research Department
Company: Oracle Corporation
Industry: Computer - Software
Press Reports Oracle Could Buy Electronic Health IT Vendor Cerner for $30B
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Oracle Corporation
Industry: Computer - Software
Company: Oracle Corporation
Industry: Computer - Software
Company: Oracle Corporation
Industry: Computer - Software
Enterprise Software: C3Q21 Earnings Recap -- Acceleration or Bust
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Oracle Corporation
Industry: Computer - Software
Strong Beat/Raise, Cloud/Support Acceleration Continues; Overweight
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Oracle Corporation
Industry: Computer - Software
Provider: Zacks Investment Research
Analyst: Research Department
Company: Oracle Corporation
Industry: Computer - Software
Provider: Zacks Investment Research
Analyst: Research Department
Company: Oracle Corporation
Industry: Computer - Software
Provider: Zacks Investment Research
Analyst: Research Department